{
  "id": "5e7744c3835f4e4777000005",
  "type": "yesno",
  "question": "Can leuprorelin acetate be used as androgen deprivation therapy?",
  "ideal_answer": "Yes, leuprorelin acetate is being used as androgen deprivation therapy.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29183006"
  ],
  "snippets": [
    {
      "text": "We investigated the health-related quality of life (HRQoL) of long-term prostate cancer patients who received leuprorelin acetate in microcapsules (LAM) for androgen-deprivation therapy (ADT).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29183006",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long-term ADT with LAM is a well-accepted, tolerated, effective, and low-burden treatment option for patients with advanced, hormone-sensitive PCa.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29183006",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}